The new shares will be listed on Nasdaq Copenhagen after registration with the Danish Business Authority. The capital increase is expected to be finalized shortly. The increase is effected without any preemption rights for the existing shareholders of the company or others.
🌍 Genmab (GMAB) - Form 6-K Filing
Filing Date: 2022-07-05
Accepted: 2022-07-05 14:11:58
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: